Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage: Economic evaluation of a phase III clinical trial in Europe and Australia

Henry Glick, Richard Willke, Daniel Polsky, Ted Liana, Wayne M. Alves, Neal Kassell, Kevin Schulman

Research output: Contribution to journal › Review article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage: Economic evaluation of a phase III clinical trial in Europe and Australia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences